We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TDTH
2976
Trident Digital Tech Holdings Ltd Class B Ordinary Shares
TDTH
$13.6M
| $28.9K | ﹤0.01% |
3,207
+2,562
| +397% | +$48.6K |
|
2977
Health Catalyst
HCAT
$158M
| $28.7K | ﹤0.01% |
12,002
-53,417
| -82% | -$146K |
|
2978
Greenland Technologies Holding
GTEC
$14M
| $28.7K | ﹤0.01% |
46,765
+10,117
| +28% | +$11.2K |
|
2979
Wrap Technologies
WRAP
$96.4M
| $28.5K | ﹤0.01% |
11,987
-3,431
| -22% | -$8.27K |
|
2980
Austin Gold Corp
AUST
$13.1M
| $28.3K | ﹤0.01% |
19,146
-2,817
| -13% | -$5.29K |
|
|
AGRZ
2981
Agroz Inc. Class A Ordinary Shares
AGRZ
$4.77M
| $28.3K | ﹤0.01% |
+36,705
| New | +$115K |
|
2982
CaliberCos
CWD
$4.51M
| $28.1K | ﹤0.01% |
+22,680
| New | +$60.8K |
|
2983
HeartCore Enterprises
HTCR
$3.27M
| $28.1K | ﹤0.01% |
+4,606
| New | +$56.3K |
|
2984
Marti Technologies
MRT
$143M
| $28K | ﹤0.01% |
+11,805
| New | +$28K |
|
2985
Grove Collaborative
GROV
$46.7M
| $27.8K | ﹤0.01% |
25,237
+4,058
| +19% | +$5.53K |
|
2986
Roma Green Finance Ltd
ROMA
$587M
| $27.7K | ﹤0.01% |
16,611
-6,837
| -29% | -$17.6K |
|
2987
BuzzFeed
BZFD
$104M
| $27.7K | ﹤0.01% |
29,796
-11,914
| -29% | -$15.1K |
|
|
IPM
2988
Intelligent Protection Management Corp
IPM
$23.5M
| $27.7K | ﹤0.01% |
+16,085
| New | +$30.7K |
|
2989
Research Frontiers
REFR
$15.2M
| $27.6K | ﹤0.01% |
+21,057
| New | +$35.6K |
|
|
UFG
2990
Uni-Fuels Holdings
UFG
$22.7M
| $27.2K | ﹤0.01% |
40,016
-28,153
| -41% | -$29.6K |
|
2991
Zevia
ZVIA
$116M
| $27.2K | ﹤0.01% |
11,704
-15,993
| -58% | -$39.7K |
|
|
NXXT
2992
NextNRG Inc
NXXT
$47.3M
| $26.9K | ﹤0.01% |
+18,518
| New | +$31.9K |
|
2993
Pasithea Therapeutics
KTTA
$15M
| $26.8K | ﹤0.01% |
20,783
-13,575
| -40% | -$11.9K |
|
2994
Paramount Gold Nevada
PZG
$93.5M
| $26.7K | ﹤0.01% |
21,169
+4,272
| +25% | +$4.94K |
|
|
CHMI
2995
Cherry Hill Mortgage Investment Corp
CHMI
$81.9M
| $26.7K | ﹤0.01% |
+10,454
| New | +$25.5K |
|
|
RBOT
2996
DELISTED
Vicarious Surgical
RBOT
| $26.6K | ﹤0.01% |
+12,256
| New | +$49.8K |
|
2997
Genius Group
GNS
$30.4M
| $26.4K | ﹤0.01% |
+46,032
| New | +$35.5K |
|
2998
Oragenics
OGEN
$2.24M
| $26.4K | ﹤0.01% |
+33,747
| New | +$36.6K |
|
|
TJGC
2999
TJGC Group Limited Ordinary Shares
TJGC
$51.9M
| $26.4K | ﹤0.01% |
+9,272
| New | +$31.7K |
|
3000
PDS Biotechnology
PDSB
$38.6M
| $26.3K | ﹤0.01% |
34,218
+14,519
| +74% | +$13.1K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.